0001179110-17-010223.txt : 20170707
0001179110-17-010223.hdr.sgml : 20170707
20170707163730
ACCESSION NUMBER: 0001179110-17-010223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170705
FILED AS OF DATE: 20170707
DATE AS OF CHANGE: 20170707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 17955568
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-05
0
0001597264
Blueprint Medicines Corp
BPMC
0001177082
LYNCH DANIEL
C/O BLUEPRINT MEDICINES CORPORATION
38 SIDNEY STREET, SUITE 200
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2017-07-05
4
S
0
7500
55.06
D
211842
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Christopher Frankenfield, Attorney-in-Fact
2017-07-07